Mana Therapeutics lands $35m Series A

Mana Therapeutics, a creator of allogeneic cell therapies that target multiple cancer antigens, has raised $35 million in Series A financing.

Mana Therapeutics, a creator of allogeneic cell therapies that target multiple cancer antigens, has raised $35 million in Series A financing. Cobro Ventures and Lightchain Capital led the round.

Source: Press Release